Literature DB >> 20796155

Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma.

Lifang Fan1, Mylinh T Mac, David P Frishberg, Xuemo Fan, Deepti Dhall, Bonnie L Balzer, Stephen A Geller, Hanlin L Wang.   

Abstract

BACKGROUND AND AIM: Hepatocellular carcinoma (HCC) is unique in that the presence of vascular invasion significantly changes tumor stage. Even though searching for vascular invasion is a common practice in surgical pathology, there appears to be a great variation among pathologists in its recognition. This study was designed to assess whether HCC could be accurately staged using vascular invasion as a staging parameter.
METHODS: The interobserver and intraobserver agreement for vascular invasion was analyzed in 126 liver resections for HCC. Selected slides were circulated twice among six pathologists for independent review using their own criteria. One to three representative images from 26 equivocal cases selected by one of the authors were re-evaluated by the pathologists. The presence or absence of vascular invasion on each slide or image was recorded as yes or no. The results were analyzed using unweighted kappa statistic analysis for multiple raters.
RESULTS: The interobserver agreement was moderate on two slide circulations with kappa values of 0.50 (95% confidence interval 0.45-0.55) and 0.43 (0.38-0.47), respectively. The kappa value dropped significantly to 0.19 (0.09-0.29) on selected images photographed from controversial cases. The intraobserver agreement was moderate, with kappa values ranging from 0.23 to 0.56 (mean = 0.45).
CONCLUSIONS: Pathologists can reproducibly recognize vascular invasion in many HCC cases but may have difficulty in equivocal cases, which may lead to either understaging or overstaging of the tumors. This may have a significant impact on prognostic assessment and therapeutic decision making. Our observations indicate the need for improved definition for vascular invasion in HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20796155     DOI: 10.1111/j.1440-1746.2010.06304.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  11 in total

1.  Hepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA.

Authors:  Mohamed Abd El-Fattah
Journal:  Indian J Gastroenterol       Date:  2017-02-14

Review 2.  Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation.

Authors:  Marta Guerrero-Misas; Manuel Rodríguez-Perálvarez; Manuel De la Mata
Journal:  World J Hepatol       Date:  2015-04-08

3.  Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.

Authors:  Shuang Liu; Hui Li; Lei Guo; Bo Zhang; Binghai Zhou; Wentao Zhang; Jian Zhou; Jia Fan; Qinghai Ye
Journal:  Oncologist       Date:  2018-12-14

4.  Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation.

Authors:  Theodore H Welling; Kevin Eddinger; Kristen Carrier; Danting Zhu; Tyler Kleaveland; Derek E Moore; Douglas E Schaubel; Peter L Abt
Journal:  Liver Transpl       Date:  2018-09       Impact factor: 5.799

Review 5.  Unveiling lymph node metastasis in early gastric cancer.

Authors:  Nari Shin; Tae-Yong Jeon; Gwang Ha Kim; Do Youn Park
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

6.  Blood Vessel Invasion in Endometrial Cancer Is One of the Mechanisms of Spread to the Cervix.

Authors:  Gunsu Kimyon Comert; Derman Basaran; Hayriye Ergin Akkoz; Burcin Celik; Selcan Sinaci; Osman Turkmen; Alper Karalok; Olcay Kandemir; Taner Turan
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

7.  Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma.

Authors:  Yong Keun Park; Sung Kyu Song; Bong-Wan Kim; Seung-Keun Park; Chul-Woon Chung; Hee-Jung Wang
Journal:  World J Surg Oncol       Date:  2017-12-19       Impact factor: 2.754

8.  Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification.

Authors:  Minjong Lee; Young Chang; Sohee Oh; Young Youn Cho; Dhong-Eun Jung; Hong Hyun Kim; Joon Yeul Nam; Hyeki Cho; Eun Ju Cho; Jeong-Hoon Lee; Su Jong Yu; Nam-Joon Yi; Kwang-Woong Lee; Dong Ho Lee; Jeong Min Lee; Jung-Hwan Yoon; Kyung-Suk Suh; Yoon Jun Kim
Journal:  Gut Liver       Date:  2018-09-15       Impact factor: 4.519

9.  Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.

Authors:  Isao Hosono; Ryoji Miyahara; Kazuhiro Furukawa; Kohei Funasaka; Tsunaki Sawada; Keiko Maeda; Takeshi Yamamura; Takuya Ishikawa; Eizaburo Ohno; Masanao Nakamura; Hiroki Kawashima; Takio Yokoi; Tetsuya Tsukamoto; Yoshiki Hirooka; Mitsuhiro Fujishiro
Journal:  BMC Gastroenterol       Date:  2020-06-05       Impact factor: 3.067

10.  Pathological diagnostic criterion of blood and lymphatic vessel invasion in colorectal cancer: a framework for developing an objective pathological diagnostic system using the Delphi method, from the Pathology Working Group of the Japanese Society for Cancer of the Colon and Rectum.

Authors:  Motohiro Kojima; Hideyuki Shimazaki; Keiichi Iwaya; Masayoshi Kage; Jun Akiba; Yasuo Ohkura; Shinichiro Horiguchi; Kohei Shomori; Ryoji Kushima; Yoichi Ajioka; Shogo Nomura; Atsushi Ochiai
Journal:  J Clin Pathol       Date:  2013-04-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.